Loading clinical trials...
Loading clinical trials...
Investigating the Effects of Lumbrokinase in Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Conditions
Interventions
Lumbrokinase
Locations
1
United States
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
New York, New York, United States
Start Date
October 9, 2024
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 13, 2026
NCT06631287
NCT06871293
NCT06932237
NCT06721949
NCT06511063
NCT07435805
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions